CogState (CGS.AX) Stock Price
CogState Price
CogState (CGS.AX) Stock | ISIN AU000000CGS8. The current CogState stock price is 1.97 USD (2026). Revenue is 59.87 M USD. Net income is 12.24 M USD. The P/E ratio is 28. Market capitalization is 342.9 M USD. CogState operates in the Health sector.
Over the last 19 years CogState grew revenue by 20% annually, reaching 53.09 M USD. Earnings per share have grown at 8.5% per year over the last 16 years. For CogState, the net margin of 19.1% is up versus 16% a few years ago. At today's price the dividend yield works out to roughly 1.45%.
CogState stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of CogState over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how CogState stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing CogState's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | CogState Price |
|---|
CogState Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
CogState Income Statement, Balance Sheet, Cash Flow Statement
| REVENUE (M USD) |
|---|
| REVENUE GROWTH (%) |
| GROSS MARGIN (%) |
| GROSS INCOME (M USD) |
| NET INCOME (M USD) |
| NET INCOME GROWTH (%) |
| SHARES (M) |
| DOCUMENTS |
| 2023 | 2024 | 2025 | 2026e | 2027e | 2028e | 2029e | 2030e |
|---|---|---|---|---|---|---|---|
| 40 | 43 | 53 | 59 | 66 | 78 | 95 | 106 |
| -11.11 | 7.5 | 23.26 | 11.32 | 11.86 | 18.18 | 21.79 | 11.58 |
| 50 | 55.81 | 60.38 | 54.24 | 48.48 | 41.03 | 33.68 | 30.19 |
| 20 | 24 | 32 | 32 | 32 | 32 | 32 | 32 |
| 3 | 5 | 10 | 12 | 14 | 19 | 22 | 25 |
| -57.14 | 66.67 | 100 | 20 | 16.67 | 35.71 | 15.79 | 13.64 |
| 176.34 | 173.1 | 174.01 | 174.01 | 174.01 | 174.01 | 174.01 | 174.01 |
| – | – | – | – | – | – | – | – |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales CogState generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue CogState retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare CogState's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares CogState has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against CogState's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
CogState stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
CogState Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
CogState business model & stock analysis
CogState SWOT Analysis
Strengths
- Strong reputation in the cognitive assessment industry.
- Leading provider of computerized cognitive tests and clinical trial services.
- Extensive experience and expertise in developing and commercializing innovative cognitive assessment solutions.
- Robust intellectual property portfolio, providing a competitive advantage.
Weaknesses
- Dependency on a relatively small number of key clients for a significant portion of revenue.
- Limited market presence outside of North America and Europe.
- Relatively high research and development costs, impacting profitability.
Opportunities
- Increasing demand for cognitive assessment tools in healthcare, research, and pharmaceutical industries.
- Potential for expansion into emerging markets, such as Asia-Pacific and Latin America.
- Growing awareness and importance of early detection and intervention for cognitive disorders, creating a larger addressable market.
Threats
- Intense competition from other cognitive assessment providers.
- Regulatory challenges and compliance requirements in different countries.
- Economic downturn or budget constraints impacting customer spending on cognitive assessment solutions.
CogState Eulerpool Fair Value
CogState historical P/E ratio, EBIT multiple, and P/S ratio
CogState annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
CogState shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
CogState Dividend History
1 years of dividend payments
CogState dividend history and estimates
Max
Details
CogState dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
CogState shareholder structure
| % | Name |
|---|---|
16.41709% | |
13.62815% | |
8.90596% | |
4.88485% | |
3.67792% | |
2.43537% | |
1.96539% | |
1.86216% | |
0.88327% | |
0.86201% |
CogState Executives and Management Board
Mr. Brad O'Connor
Chief Executive Officer, Managing Director, Executive Director · since 2004
Mr. Darren Watson
Chief Financial Officer
Mr. Chris Edgar
Chief Scientific Officer
Mr. Martyn Myer
Non-Executive Chairman of the Board
Ms. Ingrid Player
Independent Non-Executive Director
Frequently asked questions about CogState
CogState Ltd is a leading provider of cognitive testing services for clinical trials, academic research, and healthcare. The company's business model revolves around using their digital tools and technologies to measure and enhance cognitive function in patients. By collaborating with pharmaceutical companies, academic institutions, and healthcare organizations, CogState Ltd aims to improve patient outcomes and accelerate the development of new treatments. With their expertise and extensive database, CogState Ltd offers customized solutions and prognostic insights to address the cognitive challenges faced in various industries.
CogState stock
CogState Peer Group
CogState Ticker
CogState FIGI
All fundamentals and in-depth analysis of CogState
Our stock analysis for CogState Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CogState Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.